Strongbridge Biopharma plc Contracts & Agreements
29 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (1)
- Human Resources (7)
- Intellectual Property (1)
- Real Estate (1)
- Uncategorized (8)
- First Amendment to Term Loan Agreement, dated July 23, 2021, among Strongbridge Biopharma plc, Strongbridge U.S., Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on July 26, 2021)
- Lock-Up Agreement, dated July 23, 2021, between Avenue Venture Opportunities Fund, L.P. and Strongbridge Biopharma plc (Filed With SEC on July 26, 2021)
- Underwriting Agreement, dated as of September 16, 2020, by and between Strongbridge Biopharma plc and Jefferies LLC and Stifel, Nicolaus and Company, Incorporated, as... (Filed With SEC on September 18, 2020)
- Employment Agreement, dated as of July 2, 2020, by and between Strongbridge U.S. Inc. and John Johnson (Filed With SEC on August 4, 2020)
- Amendment to Executive Chairman Agreement (Filed With SEC on April 10, 2020)
- Description of Ordinary Shares (Filed With SEC on February 28, 2020)
- Form of Indemnification Agreement (Filed With SEC on February 28, 2020)
- Form of Restricted Stock Unit Award Agreement under the Strongbridge Biopharma Non-Employee Director Equity Compensation Plan (Filed With SEC on February 28, 2020)
- Executive Chairman Agreement, dated as of November 1, 2019, by and between Strongbridge Biopharma plc and John Johnson (Filed With SEC on February 28, 2020)
- Amendment to Option Award Agreements, dated as of November 26, 2019, by and between Strongbridge Biopharma plc and Matthew Pauls (Filed With SEC on February 28, 2020)
- Consulting Agreement by and between Strongbridge U.S. Inc. and A. Brian Davis, dated as of September 3, 2019 (Filed With SEC on November 7, 2019)
- Strongbridge Biopharma plc 2015 Equity Compensation Plan (Filed With SEC on February 27, 2019)
- Strongbridge Biopharma plc Non-Employee Director Equity Compensation Plan (Filed With SEC on February 27, 2019)
- Strongbridge Biopharma plc 2017 Inducement Plan (Filed With SEC on February 27, 2019)
- Macrilen Acquisition Agreement, dated as of October 31, 2018, between Strongbridge Biopharma plc and Novo Nordisk Healthcare AG (Filed With SEC on October 31, 2018)
- Share Purchase Agreement, dated as of October 31, 2018 between Strongbridge Biopharma plc and Novo Nordisk A/S (Filed With SEC on October 31, 2018)
- Amendment No. 2 to Term Loan Agreement, dated as of June 6, 2018, by and among Strongbridge U.S. Inc., Strongbridge Biopharma Public Limited Company, Cortendo Cayman Ltd.,... (Filed With SEC on August 8, 2018)
- Strongbridge Biopharma plc 2015 Equity Compensation Plan (Filed With SEC on March 12, 2018)
- Strongbridge Biopharma plc Non-Employee Director Equity Compensation Plan (Filed With SEC on March 12, 2018)
- Strongbridge Biopharma plc 2017 Inducement Plan (Filed With SEC on March 12, 2018)
- Form of Incentive Stock Option Award Agreement under the Strongbridge Biopharma plc 2015 Equity Compensation Plan (Filed With SEC on March 12, 2018)
- Form of Nonqualified Stock Option Award Agreement under the Strongbridge Biopharma plc 2015 Equity Compensation Plan (Filed With SEC on March 12, 2018)
- Form of Restricted Stock Unit Award Agreement under the Strongbridge Biopharma plc 2015 Equity Compensation (Filed With SEC on March 12, 2018)
- Form of Nonqualified Stock Option Award Agreement under the Strongbridge Biopharma plc Non-Employee Director Equity Compensation Plan (incorporated by reference to Exhibit 10.16... (Filed With SEC on March 12, 2018)
- Lease, dated November 21, 2017, by and between Northbrook TC Equities LLC, et. al. as Landlord, and Strongbridge U.S. Inc., as Tenant (Filed With SEC on March 12, 2018)
- Form of Stock Option Award Agreement under the Strongbridge Biopharma plc 2017 Inducement Plan (Filed With SEC on March 12, 2018)
- Form of Restricted Stock Unit Award Agreement under the Strongbridge Biopharma plc 2017 Inducement Plan (Filed With SEC on March 12, 2018)
- License and Assignment Agreement, dated January 16, 2018, by and between Aeterna Zentaris GmbH and Strongbridge Ireland Limited (Filed With SEC on March 12, 2018)
- Underwriting Agreement, dated as of January 25, 2018, by and between Strongbridge Biopharma plc and Cantor Fitzgerald & Co., as representative of the several underwriters named... (Filed With SEC on January 26, 2018)
